NEW YORK (TheStreet) -- The S&P 500 is down 1.2% Thursday but not all stocks are having a bad day. Shares of Eli Lilly (LLY - Get Report) are up nearly 5% following positive data for its Jardiance drug.

The drug lowers the risk of cardiovascular disease in those who have type 2 diabetes, TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, explained on CNBC's "Mad Dash" segment. 

The safety profile of the drug is very good, he said, adding that this is a "major breakthrough" for Eli Lilly as roughly 50% of patients with type 2 diabetes die from cardiovascular disease. 

It's a horrible disease and that's why this is such a big deal, he said. 

LLY Chart
Eli Lilly LLY data by YCharts

Another stock on the rise is Lumber Liquidators (LL - Get Report), by nearly 12% to around $16. Analysts at Cantor Fitzgerald said now is the time to buy, while also assigning a price target of $18. 

However, Cramer is not impressed. He reminded viewers the stock is down a whopping 76% on the year because of the compliance issues that have plagued the company and its reputation. 

He noted Lumber Liquidators has a new chief compliance officer. Hardwood and laminate flooring is selling well, as shown by the recent success at Home Depot (HD - Get Report) and Lowe's (LOW - Get Report), Cramer said. 

However, Cramer advised that if you want exposure to carpeting and flooring without the problems of Lumber Liquidators, look at Mohawk Industries (MHK - Get Report), which despite being down over 1% Thursday is close to an all-time high. 

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.